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Abstract. 
 
The human cytomegalovirus (HCMV) gene 
products 
 
US2
 
 and 
 
US11
 
 dislocate major histocompatibil-
ity class I heavy chains from the ER and target them for 
proteasomal degradation in the cytosol. The dislocation 
reaction is inhibited by agents that affect intracellular 
redox potential and/or free thiol status, such as diamide 
and 
 
N
 
-ethylmaleimide. Subcellular fractionation experi-
ments indicate that this inhibition occurs at the stage of 
discharge from the ER into the cytosol. The T cell recep-
tor 
 
a
 
 (TCR 
 
a
 
) chain is also degraded by a similar set of 
reactions, yet in a manner independent of virally encoded 
gene products. Diamide and 
 
N
 
-ethylmaleimide likewise 
inhibit the dislocation of the full-length TCR 
 
a
 
 chain 
from the ER, as well as a truncated, mutant version of 
TCR 
 
a
 
 chain that lacks cysteine residues. Cytosolic de-
struction of glycosylated, ER-resident type I membrane 
proteins, therefore, requires maintenance of a proper 
redox potential for the initial step of removal of the 
substrate from the ER environment.
Key words: diamide • class I heavy chain • degrada-
tion • human cytomegalovirus • TCR 
 
a
 
 chain
 
M
 
ajor
 
 histocompatibility complex (MHC)
 
1
 
 class I
products play a central role in the immune re-
sponse against viral infection through their abil-
ity to guide CD8
 
1
 
 T cells to the infected cell (57, 67). To
elude the immune system, several viruses have evolved
strategies to prevent the surface expression of MHC class I
molecules (34, 65). One example is human cytomegalovi-
rus (HCMV), which encodes the
 
 US2
 
 and 
 
US11
 
 gene
products that are at least partially responsible for blocking
surface expression of MHC class I molecules (26). In cells
that express either US2 or US11, MHC class I heavy
chains are rapidly dislocated from the ER into the cytosol,
an ATP-dependent process suggested to involve the trans-
locon (Sec 61p complex) (63, 64). Once in the cytosol, the
single N-linked glycan on the class I heavy chains is re-
moved by 
 
N
 
-glycanase, and the polypeptide backbone is
degraded by the proteasome. Indeed, deglycosylated cyto-
solic forms of the MHC class I heavy chains are observed
only in the presence of proteasome inhibitors (63, 64).
Although physical removal from the ER and degrada-
tion of glycosylated type I membrane proteins by the pro-
teasome were described for HCMV US2– and US11–
induced proteolysis of class I heavy chains, it is likely that
this mode of destruction is more generally used by the cell
for turnover of misfolded and abnormal proteins in the
ER (10, 12, 28). The occurrence of ubiquitin-conjugated
intermediates of misfolded cystic fibrosis transmembrane
conductance regulator and the inhibition of its proteolysis
by lactacystin first suggested involvement of a cytosolic
destruction pathway for this multispanning membrane
protein (25, 60). The degradation of secretory proteins in
 
Saccharomyces cerevisiae
 
, such as mutant “misfolded” car-
boxypeptidase Y (CPY*), prepro 
 
a 
 
factor (pp
 
a
 
F), and the
human 
 
a
 
-1-proteinase inhibitor, occurs in the cytosol in a
proteasome-dependent manner (19, 35, 62). The transfer
of CPY* and pp
 
a
 
F from the ER into the cytosol may in-
volve the Sec61p complex (41, 42). Thus far, the molecular
mechanism of degradation of proteins that are cleared
from the ER remains poorly defined.
The maintenance of proper redox potential is critical
not only for protein folding in the ER (11, 58) but also for
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: CPY, carboxypeptidase Y; diamide, di-
azenedicarboxylic acid bis(
 
N
 
,
 
N
 
-dimethylamide); HCMV, human cyto-
megalovirus; IAA, iodoacetic acid; IAM, iodoacetamide; IEF, isoelectric
focusing; MHC, major histocompatibility complex; NEM, 
 
N
 
-ethylmaleimide;
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3
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benzyl-leucyl-leucyl-leucinal; ZL
 
3
 
VS, carboxylbenzyl-leucyl-leucyl-leucyl
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cell viability (20, 48, 54). Disruption of the redox potential
affects the function of ER-resident and cytosolic proteins
(1, 7, 33, 56). While the environment of the cytosol favors
the reduction of disulfide bonds and maintenance of cys-
teines in the free 
 
2
 
SH form, the more oxidizing environ-
ment of the ER is conducive to the formation of disulfide
bonds, a reaction thought to involve protein disulfide
isomerase (PDI) (15). The redox potential of the cell is
maintained by the equilibrium between reduced glu-
tathione and its oxidized form, but it can be manipulated
experimentally (23). Diazenedicarboxylic acid bis(
 
N
 
,
 
N
 
-
dimethylamide) (diamide) is an oxidant that targets the
thiols of reduced glutathione and of proteins containing
free SH groups (29, 30). The action of diamide induces the
formation of disulfide bonds in which intermediates of
thiol-diamide are generated, as diagrammed for gluta-
thione in Fig. 1. The thiol-diamide intermediate may also
cross-link proteins with vicinal free cysteines through an
attack of the latter on the thiol-diamide adduct and could
do likewise with free intrachain 
 
2
 
SH groups, in effect pro-
moting the formation of disulfide bonds much like oxi-
dized glutathione (1, 3).
Changing the redox environment of US2- and US11-
expressing cells in favor of a more reduced state by the ad-
dition of the reducing agent DTT did not influence the
rate of degradation of class I heavy chains, although such
treatment interfered with the generation of the deglycosy-
lated intermediate (64). We show here that degradation of
 
class I heavy chains in US2/US11
 
1
 
 cells is affected when a
more oxidizing environment is imposed by the addition of
diamide or the alkylating agent 
 
N
 
-ethylmaleimide (NEM).
We show that the removal of type I membrane proteins
from the ER critically depends on redox potential and is
largely abolished by even modest concentrations of dia-
mide and NEM.
 
Materials and Methods
 
Materials and Inhibitors
 
Diamide, iodoacetic acid (IAA), iodoacetamide (IAM), and NEM were
purchased from Sigma Chemical Co. (St. Louis, MO). The proteasome in-
hibitors carboxylbenzyl-leucyl-leucyl-leucinal (ZL
 
3
 
H) and carboxylben-
zyl-leucyl-leucyl-leucyl vinylsulfone (ZL
 
3
 
VS) were synthesized as de-
scribed (9, 63).
 
Cell Lines
 
U373-MG astrocytoma cells (control cells), US2 transfectants (US2
 
1
 
),
and US11 transfectants (US11
 
1
 
) were prepared as described (26, 27).
Daudi cells (American Type Culture Collection, Rockville, MD), which
do not express 
 
b
 
2
 
m (17, 37), were cultured in RPMI supplemented with
10% fetal calf serum. COS-1 cells were cultured in DME medium supple-
mented with 10% fetal calf serum.
 
Antibodies
 
Rabbit anti–class I heavy chain serum (
 
a
 
HC) (36) and the monoclonal an-
tibody HC10 (52) recognize free class I heavy chains. W6/32 is a mono-
clonal antibody that recognizes assembled class I molecules (39). The rab-
bit anti-US2 serum was generated by immunizing rabbits with a fragment
of US2 (amino acids 22–160 [13]) expressed in 
 
Escherichia coli
 
. The poly-
clonal rabbit antiserum R284 was raised against inclusion bodies of re-
combinant T cell receptor 
 
a
 
 (TCR 
 
a
 
) chain expressed in
 
 Escherichia coli
 
(22). The anti–human transferrin receptor antibody (
 
a
 
TfR) is a mono-
clonal antibody (66Ig10) (59).
 
cDNA and Transfection
 
The cDNA of TCR 
 
a
 
 chain (HA 1.7) (18) and a truncated and cysteine-
free form of TCR 
 
a
 
 (V
 
a
 
TM
 
D
 
C
 
) chain was subcloned into the eukaryotic
expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA), and liposome-
mediated transfection was performed as described (22).
 
Gel Electrophoresis
 
SDS-PAGE, one-dimensional isoelectric focusing (IEF), and fluorogra-
phy were performed as described (43).
 
Pulse-Chase Experiments
 
Cells were detached by trypsin treatment and then incubated with me-
thionine- and cysteine-free DME with or without proteasome inhibitor
ZL
 
3
 
H (25 
 
m
 
M) or ZL
 
3
 
VS (50 
 
m
 
M) for 1 h at 37
 
8
 
C. Cells were labeled by
incubation with 400 
 
m
 
Ci of [
 
35
 
S]methionine/cysteine (1,200 Ci/mmol;
NEN-Dupont, Boston, MA) per milliliter at 37
 
8
 
C for the indicated times
and chased with methionine- and cysteine-free DME supplemented with
nonradiolabeled methionine and cysteine to a final concentration of 2.5
and 0.5 mM at 37
 
8
 
C for the indicated times. Cell lysis and immunoprecipi-
tation were performed as described (4). In experiments involving inclu-
sion of diamide or NEM, they were added at the onset of the chase unless
indicated otherwise.
 
Alkylation of MHC Class I Molecules in US2
 
1
 
 
 
and
Control Cells
 
A pulse-chase experiment was performed with US2
 
1
 
and control cells in
the presence of ZL
 
3
 
H (20 
 
m
 
M). The cells were pulsed for 3 min, chased for
3, 8, and 30 min, and lysed in a 0.5% NP-40 lysis mix containing iodoaceta-
mide (10 mM) or iodoacetic acid (10 mM). Class I molecules were immu-
noprecipitated with either 
 
a
 
HC or W6/32. A 3-min chase sample from
Figure 1.( A ) Diamide induces the formation of disulfide bonds
(i.e., reduced glutathione [GS2] is converted to its oxidized form
[GSSG]). (B) NEM irreversibly alkylates free sulfhydryls (2SR). 
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control cells was immunoprecipitated with 
 
a
 
HC and digested with bacte-
rial 
 
N
 
-glycanase (PNG; Boehringer Mannheim GmbH, Mannheim Ger-
many) before loading onto the gel. The proteins were resolved by one-
dimensional IEF or SDS–polyacrylamide gel (12.5%).
 
Infection of Control Cells with a Recombinant
Vaccinia Virus Expressing a Truncated Form of
HCMV US2 (US2-150)
 
Recombinant vaccinia virus (vvUS2-150) expressing a truncated form of
HCMV US2 (amino acids 1–150) (US2-150) was a generous gift from Dr.
John Yewdell (National Institutes of Health, Bethesda, MD). Control
cells were infected with vvUS2-150 at a multiplicity of infection of 5 for 1 h
in 500 
 
m
 
l of DME medium at 37
 
8
 
C. A 10-fold excess of DME medium sup-
plemented with 10% fetal calf serum was added, and the infected cells
were incubated for 3 h at 37
 
8
 
C. Cells were pulsed for 10 min with [
 
35
 
S]me-
thionine and chased for 0 and 20 min as described above, except that 1 mM
diamide was added to half of the cells after the 0-min chase point. Cells
were lysed in 1% digitonin (wt/vol) in 25 mM Hepes, 150 mM potassium
acetate, pH 7.7. Properly folded class I molecules and US2 were immuno-
precipitated from the cell lysates using W6/32 and 
 
a
 
US2 antibodies, re-
spectively (4). Precipitates were washed at 4
 
8
 
C with 0.2% digitonin in 25 mM
Hepes, 150 mM potassium acetate, pH 7.7. Recovery of US2-150 from
W6/32 precipitates was effectuated by incubating half of the W6/32 precip-
itates at 95
 
8
 
C for 5 min in the presence of 1% SDS followed by a 10-fold
dilution with 0.5% NP-40 lysis mix (4), and US2-150 was immunoprecipi-
tated with 
 
a
 
US2 antibodies. The precipitates were then analyzed by SDS-
PAGE.
 
Subcellular Fractionation
 
Approximately 5 
 
3 
 
10
 
7
 
 US2
 
1
 
 
 
cells were pulsed in 500 
 
m
 
Ci [
 
35
 
S]methio-
nine-cysteine/ml for 10 min. NEM (1 mM) or diamide (1 mM) was added
5 min into the pulse. Cells were chased for 0, 20, and 40 min and then ho-
mogenized by passing the cells (suspended in 250 mM sucrose, 10 mM
Tris, pH 7.4) 14 times through a ball bearing homogenizer (0.012-mm
gap). Homogenized cells were spun (model TLA 100 ultracentrifuge,
TLA 100.2 rotor; Beckman Instruments, Fullerton, CA) at 100,000 
 
g
 
 for 1 h.
The 100,000-
 
g
 
 supernatant fraction was removed and adjusted to a final
concentration of 0.5% NP-40, 125 mM sucrose. Unfractionated cells were
lysed in 0.5% NP-40, 125 mM sucrose. All samples were subjected to im-
munoprecipitation using 
 
a
 
HC, 
 
a
 
US2, or 
 
a
 
TfR.
COS-1 cells transfected with TCR 
 
a
 
 chain were pulsed for 10 min with
[
 
35
 
S]methionine-cysteine and chased for 2 h either in the presence or ab-
sence of ZL
 
3
 
H and/or 1 mM diamide. These cells were suspended in 10 mM
Tris-Cl, 250 mM glucose, 1 mM EDTA, pH 7.6, and homogenized with a
Dounce-type homogenizer using 50 strokes. The resulting homogenate
was spun in a table top centrifuge (model 5415 C; Eppendorf Scientific,
Madison, WI) at 1,000 
 
g
 
 for 10 min, and then the supernatant was centri-
fuged for 1 h (as above) at 100,000 
 
g
 
. Pooled pellets of 1,000 and 100,000 
 
g
 
and the supernatant were resuspended in 0.5% NP-40 lysis buffer and sub-
jected to immunoprecipitation with anti–TCR 
 
a
 
 chain serum. The precipi-
tates were analyzed by SDS-PAGE.
 
Degradation of a Truncated Form of TCR 
 
a
 
 Chain 
(V
 
a
 
TM
 
D
 
C
 
) Lacking Cysteines
 
V
 
a
 
TM
 
D
 
C
 
, a truncated and cysteine-free form of TCR 
 
a
 
 (HA 1.7), was gen-
erated as follows: The constant domain of TCR 
 
a
 
 chain as well as Cys 209
were deleted by fusing the variable domain (Gln1-Pro121) in frame to the
hinge region at Lys216. The remaining cysteines (Cys23 and Cys90) were
changed to alanine by site-directed mutagenesis, resulting in a TCR 
 
a
 
chain entirely devoid of cysteines. All cloning steps were performed in the
cloning vector pSP72 (Promega Corp., Madison, WI). Sequence analysis
confirmed the nucleotide sequence of the cDNA, which was then cloned
into the eukaryotic expression vector pcDNA3.1 (Invitrogen).
COS cells transiently transfected with TCR 
 
a
 
 chain or V
 
a
 
TM
 
D
 
C 
 
were
metabolically labeled for 30 min, lysed, and immunoprecipitated using
rabbit anti–TCR 
 
a
 
 chain serum. Half of the precipitates were digested
with endoglycosidase H and separated by SDS-PAGE. In addition, COS
cells transiently transfected with V
 
a
 
TM
 
D
 
C 
 
were subjected to a pulse-chase
experiment either in the absence of any drugs or in the presence of either
2 mM diamide or 25 
 
m
 
M ZL
 
3
 
H. Cells were lysed by boiling for 5 min twice
in 300 
 
m
 
l PBS containing 5 mM DTT and 1% SDS. In between the boiling
steps, the lysates were passed 10 times through a 22.75-gauge needle to re-
duce viscosity. NEM was then added to a final concentration of 10 mM,
and the lysate was finally diluted 10-fold in NP-40 lysis buffer. Anti–TCR
 
a
 
 chain serum was used to immunoprecipitate VaTMDC from cell lysates.
The precipitates were analyzed by SDS-PAGE and quantitated by densi-
tometry.
Results
The Reduction of the Intrachain S-S Bonds
of the Class I Heavy Chain in US21 Cells Precedes
Deglycosylation of the Heavy Chains
The extracellular domain of MHC class I heavy chain con-
tains four cysteines that form two intrachain disulfide
bonds, one of which stabilizes the compactly folded a3 im-
munoglobulin domain (6, 47). Because translocation of a
protein across a biological membrane generally requires
the polypeptide to be in an unfolded state (44), it is likely
that reduction of the intrachain disulfide bonds occurs be-
fore dislocation. In US2-expressing cells, we examined the
temporal relationship between the reduction of the intra-
chain disulfide bonds in the class I heavy chain and its dis-
location across the ER into the cytosol, as judged by the
removal of its N-linked glycan by N-glycanase. Even
though dislocation and deglycosylation are two distinct
processes, the kinetics of each reaction do not allow us to
distinguish temporally between the two events. However,
only a minimal amount of deglycosylated class I heavy
chains is associated with membrane fractions, suggesting
that the majority of the deglycosylated heavy chains has
been dislocated into the cytosol (63, 64). The free 2SH
content of class I heavy chains was monitored by the addi-
tion of either IAA, which results in the acquisition of a
negative charge for each 2SH modified, or IAM, which
produces no charge difference (Fig. 2 A). Alkylated sam-
ples were analyzed by isoelectric focusing (IEF). The mul-
titude of class I products expressed in most heterozygous
cells lines results in heterogeneous banding patterns on
IEF (36, 53).
The removal of the single N-linked glycan from the class
I heavy chains results in conversion of Asn 86 to Asp,
causing the heavy chains to acquire a negative charge (63,
64) (Fig. 2 B, compare lanes 2–4, arrows). A similar result
is obtained when class I heavy chains from control cells
were digested with N-glycanase in vitro (63) (Fig. 2 B, lane
1). If N-glycanase digestion were to precede the reduction
of disulfide bonds, a comparison of samples treated with
IAA and IAM should reveal the presence of alkylated, de-
glycosylated (Asp-containing) intermediates at the earliest
time points of chase. However, if reduction precedes N-gly-
canase attack, then alkylated glycosylated class I heavy
chains would be observed at the earliest time points of
chase, to be followed by the appearance of the deglycosy-
lated species.
Pulse-chase experiments were performed on US21 cells
in the presence of proteasome inhibitor, in conjunction
with alkylation using either IAA or IAM. Class I heavy
chains were immunoprecipitated using a rabbit anti–heavy
chain (aHC) serum, a reagent that reacts selectively with
free heavy chains, or using the monoclonal antibody W6/32,
which reacts with properly folded, b2m-associated heavy
chains. The immunoprecipitates were then analyzed byThe Journal of Cell Biology, Volume 142, 1998 368
IEF or SDS-PAGE (43) (Fig. 2 B). In US21 cells, at
early time points of chase we detected the presence of
more heavily alkylated species (Fig. 2 B, lanes 9 and 10, as-
terisks) that are absent from the control cells (Fig. 2 B,
lane 15). At this time point, no deglycosylated intermedi-
ates were detected in the US21 cells (Fig. 2 B, SDS-PAGE
section, compare lanes 9 and 10). If the N-glycanase sub-
strate is suppressed by prior treatment of cells with tunica-
mycin, a strategy used to avoid introduction of additional
negative charges by cellular N-glycanase, we still observe
increased representation of more heavily alkylated class I
heavy chains in US21 cells as compared with control cells
(Fig. 2 B, lanes 12–15). We therefore conclude that the di-
sulfide bridges of the class I heavy chains in US21 cells are
reduced before the removal of its N-linked glycan.
For completely folded class I molecules recovered with
W6/32, there was no change in disulfide bonding status in
either US21 or control cells (Fig. 2 C), but there was a
Figure 2. Intrachain -S-S- bonds in MHC class I heavy
chains are reduced before deglycosylation. (A) IAA or
IAM can be used as thiol-specific probes. Comparison
of molecules alkylated with either IAA or IAM can be
used to assess the free sulfhydryl content of the mole-
cule of interest. Alkylation of MHC class I heavy chains
(A or B) in US21 cells with IAA introduces a negative
charge for each modified free 2SH group (D), but no
charge is introduced upon alkylation with IAM (C). An
additional negative charge is introduced when the
N-linked glycan on the class I heavy chain is removed by
N-glycanase (E and F), converting the Asn to an Asp
residue. These charge differences can be resolved using
IEF. Pulse-chase experiments were performed on US21 and control cells in the presence of the proteasome inhibitor ZL3H. The cells
were lysed in the presence of either IAA or IAM. MHC class I molecules were recovered by immunoprecipitation with either anti–class
I heavy chain (aHC), specific for free heavy chains (B), or with W6/32, specific for assembled class I molecules composed of heavy chain
and light chain (b2m) (C). The immunoprecipitates were resolved by either IEF or SDS-PAGE. The comparison of samples alkylated
with IAA and IAM immediately reveals the reduced state of the free class I heavy chains (B, compare lanes 2–7 and 9–14), as judged
from the more acidic isoelectric points of heavy chains (B, asterisks, lanes 9–14). Treatment of US21 cells with tunicamycin prevents the
charge shift introduced by the action of N-glycanase (B, arrows, lanes 3 and 4). For reference, a sample obtained at the 3-min chase
point from control cells was digested with bacterial PNGase F and analyzed in parallel (lane 1). A charge shift of class I heavy chains re-
covered using W6/32 from US21 and control cells is observed when these samples were alkylated with IAA (C, lanes 6–10), but not
when alkylated with IAM (C, lanes 1–5).Tortorella et al. Degradation of ER Membrane Proteins in the Cytosol 369
steady decline in immunoreactive material in US21 cells
because of unfolding and attendant epitope loss (64). A
charge shift was observed for folded, W6/32-reactive class
I molecules in both control and US21 cells upon alkylation
with iodoacetic acid (Fig. 2 C, compare lanes 1–5 and 6–10),
which is almost certainly attributable to a free Cys in the
cytoplasmic tail (45). The b2m molecule does not contain
any free cysteines, and therefore its isoelectric point does
not shift upon alkylation with IAA (Fig. 2 C, compare
lanes 1 and 6). Given the kinetics with which reduction of
intrachain -S-S- bonds and deglycosylation take place,
pulse-chase experiments do not allow any further tempo-
ral resolution of these processes. Nonetheless, our data
show that reduction of intrachain disulfide bonds precedes
N-glycanase attack.
Degradation of Class I Heavy Chains in US21 Cells Is 
Inhibited by Diamide and NEM
Free class I heavy chains occur in a reduced state before
deglycosylation and probably dislocation in a US2-depen-
dent manner (Fig. 2). Do dislocation of class I heavy
chains from the ER and deglycosylation require reducing
conditions? We shifted the redox potential of the cell to-
wards a more oxidizing state by addition of either diamide
or NEM and examined degradation of class I heavy chains
in US21 and US111 cells. US21 cells were pulse-labeled in
the presence and absence of the proteasome inhibitor
ZL3H (63, 64) and chased in the absence or presence of
the indicated concentrations of diamide (Fig. 3). At 1 mM
diamide, the degradation of free class I heavy chains was
inhibited by 65% in the absence of the proteasome inhibi-
tor (Fig. 3 D). In the presence of the proteasome inhibitor
and 1 mM diamide, 80% of glycosylated class I heavy
chains were recovered at the 25-min chase point compared
with 30% of the glycosylated class I heavy chains recov-
ered from untreated cells (Fig. 3). The conversion of gly-
cosylated class I heavy chains to the deglycosylated inter-
mediate was significantly inhibited in diamide-treated
US21 cells and occurs within minutes of diamide addition
(data not shown). Comparable findings were obtained for
cells expressing US11 (Fig. 4, A and B).
In a similar set of experiments, we examined the effects
of different concentrations of the alkylating agent NEM
on US2-dependent degradation of class I heavy chains
(Fig. 5). Inhibition of both degradation and conversion of
glycosylated heavy chains to the intermediate was ob-
served at concentrations of NEM as low as 0.5 mM (Fig. 5,
A and D). Free class I heavy chains recovered from NEM-
treated cells migrate more slowly on SDS-PAGE than
their counterparts for untreated cells (Figs. 5 and 6), an ef-
fect we attribute to the formation of covalent adducts be-
tween NEM and free 2SH groups on the class I heavy
chains. We conclude that the degradation of the class I
heavy chains in US21 cells and conversion of heavy chain
Figure 3. Diamide suppresses the conversion of glycosylated
class I heavy chains to its deglycosylated intermediate in US21
cells. US21 cells treated with or without the proteasome inhibitor
ZL3H were pulsed for 10 min and chased for 0 and 25 min. Dia-
mide was added at the onset of the chase at the indicated concen-
trations. Cell lysates were immunoprecipitated with either the
anti–class I heavy chain monoclonal antibody HC10 (A), W6/32
(B), or anti-US2 (aUS2) (C). The immunoprecipitates were ana-
lyzed by SDS-PAGE (12.5%). While HC10 recovers free class
heavy chains with (1CHO) or without (2CHO) an N-linked gly-
can, W6/32 immunoprecipitates only properly folded class I
heavy chains (HC1CHO) associated with glycosylated-US2
(US21CHO) and b2m. The reduced recovery of radiolabeled
b2m in W6/32 precipitates from US21 cells (compare Figs. 3 and
7) is possibly due to loss of b2m in the course of washing, replace-
ment of b2m with US2, or the destabilization of the interaction of
b2m and class I heavy chain by US2. The anti-US2 serum recog-
nizes both nonglycosylated (2CHO) and glycosylated US2
(1CHO). The amount of the glycosylated class I heavy chains re-
covered from the 0- and 25-min chase points using HC10 was
quantitated using a Fuji PhosphorImager. The percentage of gly-
cosylated class I heavy chains (HC1CHO) at different diamide
concentrations represents the relative amount of the class I heavy
chains recovered at the 25-min chase compared with the 0-min
chase point, which was used as the standard amount of glycosy-
lated heavy chain (D).The Journal of Cell Biology, Volume 142, 1998 370
into its deglycosylated intermediate is sensitive to changes
in redox potential.
The Effect of Diamide and NEM on Properly Folded 
Class I Molecules in US21, US111, and Control Cells
Properly conformed MHC class I molecules are also tar-
geted for degradation by US2 and US11, but to a lesser ex-
tent. 50% of W6/32-reactive class I heavy chains were de-
graded in US21 cells over a 25-min period in the absence
of proteasome inhibitor (Fig. 3 B). However, in the pres-
ence of the proteasome inhibitor, only 27% of the W6/32-
reactive class I heavy chains were degraded. The addition of
2 mM diamide to US21 cells inhibits degradation of W6/32-
reactive class I molecules by 80% (Fig. 3 B). The effect of
diamide on class I heavy chain breakdown was also exam-
ined in US111 cells in the presence of proteasome inhibi-
tor (Fig. 4). 80% of the properly folded class I heavy
chains in US111 cells are degraded within 30 min (Fig. 4).
However, only 24% of the W6/32-reactive class I heavy
chains were degraded when US111 cells are treated with
1 mM diamide. In fact, because dislocation was blocked
and assembly can continue in the presence of diamide
(Fig. 6), a relative increase in W6/32-reactive class I mole-
cules was seen in cells treated with diamide.
Figure 4. Diamide inhibits the conversion of the glycosylated
class I heavy chains to its deglycosylated intermediate in US111
cells. US111 cells treated with the proteasome inhibitor ZL3VS
were pulsed for 10 min and chased for 0 and 30 min. Various con-
centrations of diamide were added at the onset of the chase. Cell
lysates were immunoprecipitated with either anti–class I heavy
chains (aHC) or W6/32. The immunoprecipitates were resolved
by SDS-PAGE (12.5%). The glycosylated class I heavy chains
(1CHO) are recovered by aHC and W6/32, while the deglycosy-
lated intermediate (2CHO) is recovered with only aHC. A
quantitative analysis (B) of the effect of diamide on the recovery
of the glycosylated free (aHC) and properly folded class I heavy
chains (W6/32) in US111 cells was performed as described in Fig. 3.
Figure 5. NEM suppresses the accumulation of the deglycosy-
lated class I heavy chain intermediate in US21 cells. US21 cells
treated with or without the proteasome inhibitor ZL3VS were
pulsed for 10 min and chased for 0 and 30 min. Various concen-
trations of NEM were added at the onset of the chase as indi-
cated. Cell lysates were immunoprecipitated with either anti–
class I heavy chain (aHC) (A), W6/32 (B), or anti-US2 (aUS2)
(C). The immunoprecipitates were analyzed by SDS-PAGE
(12.5%). The glycosylated (1CHO) and deglycosylated (2CHO)
forms of the class I heavy chains and US2 are indicated. A quanti-
tative analysis (D) of the effect of NEM on the recovery of glyco-
sylated free class I heavy chains using aHC in US21 cells was per-
formed as described in Fig. 3.Tortorella et al. Degradation of ER Membrane Proteins in the Cytosol 371
Similarly, NEM prevents degradation of W6/32-reactive
class I heavy chains in a concentration-dependent fashion,
with a maximum effect at 0.75 mM NEM (Fig. 5 B). NEM
treatment does not measurably alter the mobility of W6/
32-reactive class I heavy chains, which is consistent with
the notion that the heavy chains have already formed their
intrachain disulfide bonds and contain at most a single free
cysteine in the cytoplasmic tail.
Both diamide and NEM inhibit slightly the assembly of
class I heavy chains into W6/32-reactive material (Fig. 6)
when compared with untreated cells. Yet at the concentra-
tions where dislocation and degradation were markedly
affected, diamide and NEM do not block the folding of the
class I heavy chains into properly folded class I molecules
during the chase, as monitored by immunoprecipitation
with W6/32 (Fig. 6).
The Effect of Diamide and NEM on the Degradation of 
the US2 Molecule
The amino acid sequence of US2 predicts it to be a mem-
brane protein with three potential N-linked glycan attach-
ment sites, only one of which is used (data not shown).
The US2 protein recovered from US21 cells exists in two
forms, differing by the presence or absence of a single
N-linked glycan. The nonglycosylated form of US2 was
found in the cytosol (see Fig. 8) and was degraded in a
proteasome-dependent manner (64) (Figs. 3 C and 5 C).
This suggests that the US2 molecule escorts the class I
heavy chains out of the ER lumen and into the cytosol,
where both are degraded by the proteasome (64). In pulse-
chase experiments of diamide-treated US21 cells, the re-
covery of glycosylated US2 molecules was not affected
(Fig. 3 C). However, the amount of nonglycosylated US2
decreases significantly in diamide-treated cells (Fig. 3 C)
and parallels the decreased recovery of the deglycosylated
intermediate for class I heavy chains. Similar results were
obtained in pulse-chase experiments with US21 cells in
which NEM was added at the onset of the chase (Fig. 5 C).
In diamide-treated US21 cells, there is a reduced re-
covery of US2 associated with properly folded class I
molecules (W6/32-reactive material) (Fig. 3 B). The loss of
the class I–US2 interaction in diamide-treated cells may
be a direct consequence of diamide treatment. However,
the interaction between the NH2-terminal 150 residues of
Figure 6. Diamide and NEM only moderately impede the folding
of MHC class I molecules. Control cells were pulsed for 10 min
and chased for 0, 15, and 30 min as described in Materials and
Methods. Diamide (1 mM) or NEM (0.75 mM) were added at the
onset of the chase. Lysates from untreated, diamide-treated, or
NEM-treated cells were immunoprecipitated with either aHC or
W6/32. The immunoprecipitates were analyzed by SDS-PAGE
(12.5%). Free class I heavy chains (HC) associate with b2m to
form properly folded class I molecules (W6/32-reactive material).
Figure 7. The interaction of class I heavy chains with a truncated
form of US2 (US2-150) is not affected by diamide. Control cells
infected with a recombinant vaccinia virus expressing a truncated
form of US2 (US2-150) were pulsed for 10 min and chased for 0
and 20 min in the absence or presence of 1 mM diamide. Cell ly-
sates were immunoprecipitated with either W6/32 (A) or anti-
US2 (aUS2) (C). The W6/32 immunoprecipitates recovered class
I heavy chains (HC1CHO) associated with the light chain b2m
and US2-150. The additional bands observed in A correspond to
vaccinia virus products bound to Staphylococcus aureus (used to
immobilize the immune complexes). The US2-150 associated
with properly folded class I molecules (W6/32-reactive material)
were recovered using aUS2 (B) (see Material and Methods).
Truncated US2 (US2-150) exists in a glycosylated (US2-150
(1CHO)) and nonglycosylated (US2-150 (2CHO)) form. The
immunoprecipitates were analyzed by SDS-PAGE (12.5%). Ex-
posure time of the autoradiograms from A and C, 2 d; B, 14 d.The Journal of Cell Biology, Volume 142, 1998 372
US2 and class I molecules is unaffected by diamide treat-
ment, which suggests that the interaction between class I
and US2 may involve other proteins of the degradation
machinery. A recombinant vaccinia virus that drives the
expression of US2-150 was used to infect control cells. Im-
munoprecipitation of class I molecules with W6/32 allows
the coprecipitation of class I heavy chains with the US2-
150 molecule (Fig. 7). Inclusion of diamide in the chase
mix did not affect recovery of US2-150 by coprecipitation
via the class I molecules. We conclude that the interaction
of US2 with class I molecules is itself insensitive to inclu-
sion of diamide.
Diamide and NEM Block Dislocation
Subcellular fractionation of lysates obtained from pulse-
chased US21 cells reveals the progressive release of class I
free heavy chains into the 100,000-g supernatant fraction
(cytosol) (Fig. 8). Absent from the cytosol fraction is the
membrane protein transferrin receptor, which demon-
strates the lack of membrane contamination in this frac-
tion. Addition of diamide or NEM at 5 min into the 10-
min pulse leads to an almost complete block in class I
heavy chain dislocation to the cytosol. A small amount of
the glycosylated class I heavy chains was recovered from
the cytosol in diamide-treated US21 cells. It is therefore
possible that diamide may also inhibit N-glycanase activ-
ity. The presence of carbohydrate-bearing class I heavy
chains in the cytosol (100,000-g supernatant) from dia-
mide-treated cells suggests that complete dislocation can
occur before N-linked glycan removal. The decrease of
free class I heavy chains observed in unfractionated dia-
mide-treated cells is accounted for by an increase in prop-
erly folded, W6/32-reactive molecules (Figs. 3 and 4). In
the absence of proteasome inhibitor, glycosylated class I
heavy chains do not accumulate in the cytosol, regardless
of the presence of diamide (Fig. 8).
US2 molecules were recovered from subcellular frac-
tions as described above (Fig. 8). The absence of nongly-
cosylated US2 molecules in the cytosol of fractionated
US21 cells treated with diamide or NEM is consistent with
the lack of recovery of nonglycosylated US2 at later chase
points in diamide and NEM-treated cells (Figs. 3 C, 5 C,
and 8).
The Effect of Diamide on the Degradation of
Misfolded Glycosylated Membrane Proteins in the
Absence of Viral Accessories
The canonical example of degradation of a misfolded pro-
tein in the ER is the TCR a chain (10). When the TCR a
chain is expressed in the absence of its normal molecular
partners, the other subunits of the TCR–CD3 complex, it
acquires a cytosolic disposition and is targeted for protea-
somal proteolysis (22, 66). Since this process may use a dis-
location mechanism similar to that seen for class I heavy
chains in US2/US111 cells, the fate of TCR a chains in dia-
mide-treated cells was examined. A pulse-chase experi-
ment was performed on COS cells transiently transfected
with TCR a chain alone (Fig. 9 A). The TCR a chains
were immunoprecipitated using the conformation-inde-
pendent polyclonal antiserum R284 (22). The degradation
of fully glycosylated TCR a chains was blocked in dia-
mide-treated COS cells, both in the absence and presence
of proteasome inhibitor (Fig. 9 A). However, recovery of
partially deglycosylated breakdown intermediates at later
chase points decreased in the presence of diamide. These
results are analogous to those obtained for the recovery of
deglycosylated class I heavy chains and nonglycosylated
US2 molecules at later chase times (Fig. 3).
To determine the subcellular location of the TCR a chains,
homogenates of pulse-chased COS cells transfected with
TCR a chain were subjected to a centrifugation protocol
that separates particulate and soluble fractions (see Mate-
rials and Methods) (Fig. 9 B). In diamide-treated cells, a
small fraction of the fully glycosylated TCR a chains was
recovered in the soluble fraction, as observed for the class
I heavy chains in US21 cells (Fig. 8 A). The recovery of
fully deglycosylated TCR a chains in the soluble fraction
of COS cells treated only with ZL3H is expected (22).
Figure 8. Diamide and NEM block the dislocation of class I
heavy chains from the ER to the cytosol in US21 cells. Subcellu-
lar fractionation was performed on pulse-chased US21 cells
treated with diamide or NEM in the presence or absence of the
proteasome inhibitor ZL3VS. The class I heavy chains (A), US2
molecules (B), and transferrin receptor (C) were immunoprecipi-
tated from nonfractionated cells or 100,000-g supernatant (cyto-
sol) of fractionated cells using their respective antibodies (see
Materials and Methods). The immunoprecipitates were analyzed
by SDS-PAGE (12.5%). The glycosylated (1CHO) and deglyco-
sylated (2CHO) forms of the class I heavy chains or the US2
molecules are indicated.Tortorella et al. Degradation of ER Membrane Proteins in the Cytosol 373
Removal of the reducing equivalents in the cell by the
inclusion of diamide or NEM could prevent reduction of a
substrate marked for degradation and hence dislocation.
However, diamide may also directly modify free thiols of
the dislocation machinery and inhibit its function, thus
preventing dislocation of the target substrate. To address
the former possibility, we generated a truncated version of
the TCR a chain (VaTMDC) devoid of cysteines. The TCR
a chain fragment consists of the TCR Va domain, the
TCR a transmembrane domain, and the cytoplasmic seg-
ment (Fig. 10 A). It contains one N-linked glycan and is
recognized by the rabbit anti–TCR a chain serum (Fig. 10
B). This truncated TCR a fragment is destroyed in a pro-
teasome-dependent manner as inferred from the sensitiv-
ity of degradation to inclusion of proteasome inhibitors,
and its degradation is inhibited by the addition of diamide
(Fig. 10 C). Since dislocation of the full-length TCR a
chain is blocked by diamide, we suggest that diamide di-
rectly affects the free thiols within the dislocation machin-
ery and not the substrate of dislocation. We conclude that
a fragment of TCR a chain devoid of cysteines is de-
stroyed in a diamide-sensitive manner.
Another example of a misfolded glycosylated mem-
brane protein targeted for degradation is the MHC class I
heavy chain in Daudi cells, which do not express b2m.
Consequently, the class I heavy chains are unable to form
properly folded complexes and are rapidly degraded (21,
40). The effects of diamide and NEM on the degradation
of class I heavy chains in Daudi cells were examined in a
pulse-chase experiment (Fig. 11). The addition of the pro-
teasome inhibitor ZL3VS to Daudi cells leads to the accu-
mulation of a small amount of the deglycosylated break-
down intermediate at late chase points. The accumulation
of the deglycosylated class I heavy chains at later chase
points was also observed in US21/US111 cells. In the ab-
sence of the proteasome inhibitor, both diamide and NEM
treatment of Daudi cells lead to a stabilization of class I
heavy chains during the chase and the suppression of the
deglycosylated intermediate. These results provide further
evidence that membrane proteins targeted for degradation
into the cytosol are sensitive to redox conditions.
Discussion
MHC class I heavy chains are targeted selectively for de-
struction by the HCMV gene products US2 and US11 (63,
64). This prevents surface expression of the MHC class I
molecules, presumably allowing the virus to remain unde-
tected by the immune system as long as the US2 and US11
genes are expressed. In studying this phenomenon, it has
become apparent that the virus uses an unusual mecha-
nism of destroying the class I molecule, a type I membrane
protein. The proposed model of degradation of MHC class
I heavy chains requires the cotranslational entry and gly-
cosylation of heavy chains into the ER. The class I heavy
chains are positioned either in the hydrophobic environ-
ment of the lipid bilayer or remain associated with the
translocon, the Sec61p complex. They are then presum-
ably extracted through the Sec61p complex into the cyto-
sol. The role proposed of the Sec61p complex as the port
of exit for proteins targeted for degradation in the cytosol
is supported by genetic analysis in yeast. The degradation
of the yeast mutant proteins CPY* and prepro a factor
were retarded in yeast strains harboring mutant Sec61 al-
leles (41, 42).
HCMV seems to induce the degradation of class I heavy
chains by a process that the cell would normally use to re-
move unwanted proteins from the ER. This entire process
has been documented as ER-associated degradation. We
refer to the step in which the type I membrane protein is
exported from the ER as dislocation. The model protein
that has been used in mammalian cells to study this type of
degradation is the TCR a chain. Initially, TCR a chain was
believed to be degraded in the ER itself, but more recent
studies have shown that it is degraded in the cytosol by the
proteasome (22, 66). Other misfolded membrane proteins
that are targeted for degradation after the export from the
ER are the cystic fibrosis transmembrane conductance
regulator (25, 60) and the a subunit of the Sec61p complex
Figure 9. Diamide inhibits the dislocation of the TCR a chain
from the ER into the cytosol. COS-1 cells transiently transfected
with TCR a in the absence or presence of the proteasome inhibi-
tor ZL3H were pulsed for 10 min and chased for 1.5 h (A). Dia-
mide (1 mM) was added at the onset of the chase. TCR a chain
was immunoprecipitated from cell lysates and analyzed by SDS-
PAGE (12.5%). The number of glycans attached to the TCR a
chain is indicated. COS-1 cells transiently transfected with TCR a
chain were pulsed for 10 min and chased for 2 h (B). Cell homo-
genates were subjected to differential centrifugation as described
in Materials and Methods. TCR a chains were immunoprecipi-
tated from the particulate fractions (P) and the 100,000-g super-
natant (S) and analyzed by SDS-PAGE (12.5%). A 20-kD frag-
ment of the TCR a chain has been described as a degradation
intermediate (22). 
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in yeast (5). While a compelling case can now be made for
cytosolic destruction of proteins that have been purged
from the ER, very little is known about the molecular de-
tails of this series of reactions. Here we have focused on
the role of the redox state in the ER as a variable that af-
fects the dislocation reaction.
The reduction of the intrachain disulfide bonds of the
class I heavy chains likely occurs before dislocation from
the ER (Fig. 2), which is consistent with the notion that
the heavy chains transported through the aqueous pore of
the translocon are in an unfolded state. Even fully folded,
W6/32-reactive molecules are destroyed in accelerated
fashion when US2 or US11 is present (63, 64), and there-
fore the disulfide bonds already formed can be reduced.
Because PDI is capable of mediating both oxidation of
free 
 
2
 
SH groups, as well as reduction of S-S bonds already
formed (15, 38), we consider it possible that folded class I
molecules, while in an environment of high local PDI con-
centration as would presumably be found in proximity of
the translocon, may be reduced by PDI.
Disrupting the redox potential of the cell by addition of
diamide or NEM inhibits the dislocation of class I heavy
chains from the ER to the cytosol in US2- and US11-
expressing cells. In addition, diamide inhibits the degrada-
tion of a cysteine-free truncated form of the TCR 
 
a
 
 chain,
the destruction of which is sensitive to inclusion of protea-
some inhibitors. These observations suggest that the dislo-
cation machinery must therefore contain thiols that are re-
quired for proper function. Both diamide and NEM
interact with free 
 
2
 
SH groups and may modify similar tar-
gets. Because of their predominantly reduced state, the
most likely targets for NEM and diamide are proteins in
 
Figure 10
 
. Diamide inhibits the degradation of a truncated form
of the TCR 
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 chain (V
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) lacking cysteines. A truncated
form of the TCR 
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 chain (V
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D
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) devoid of all cysteines was
generated as described in Materials and Methods (
 
A
 
). Both the
full-length TCR 
 
a
 
 chain and its truncated counterpart, V
 
a
 
TM
 
D
 
C
 
,
were recovered using a rabbit anti–TCR 
 
a
 
 chain serum from met-
abolically labeled COS cells transiently transfected with the re-
spective DNA and digested with Endo H (
 
B
 
). Degradation of
V
 
a
 
TM
 
D
 
C
 
 was examined in transiently transfected COS cells that
were metabolically labeled for 10 min and chased for 0, 45, 90,
and 180 min. Cells were either untreated or treated with ZL
 
3
 
H or
2 mM diamide. V
 
a
 
TM
 
D
 
C
 
 was recovered by immunoprecipitation
using the anti–TCR 
 
a
 
 chain serum and digested with endoglycosi-
dase H (
 
Endo H
 
). The precipitates were analyzed by SDS-PAGE
(12.5%) and quantitated by densitometry. The amount of
V
 
a
 
TM
 
D
 
C
 
 recovered under different conditions was expressed as
the percent of V
 
a
 
TM
 
D
 
C
 
 recovered at the different chase times rel-
ative to the 0-min chase point.
Figure 11. Diamide and NEM
prevents the degradation of
the MHC class I heavy chains
in Daudi cells. Daudi cells
treated with or without the
proteasome inhibitor ZL3VS
were pulsed for 10 min and
chased for 0, 1, and 2 h. To un-
treated Daudi cells, diamide
(1 mM) or NEM (1 mM) was
added at the onset of the chase.
Cell lysates from the above
experiments were immuno-
precipitated with aHC. The
immunoprecipitates were ana-
lyzed by SDS-PAGE (12.5%).
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the cytosol. Conversely, the recognition machinery of pro-
teins targeted for degradation must exist within the ER lu-
men (50). Diamide-catalyzed oxidation of class I heavy
chains does not explain why they are unable to dislocate,
because similar results are observed with NEM, which
simply alkylates free sulfhydryls. The redox state of the
free class I heavy chains recovered from NEM-treated
US21 cells is similar to that of heavy chains from un-
treated cells, yet dislocation is inhibited in NEM-treated
cells. The interaction between class I heavy chains and
US2 is not sensitive to inclusion of diamide, as inferred
from the continued ability of a truncated form of US2 to
interact with class I molecules in the presence of diamide.
Hence, diamide must be affecting additional factors con-
taining free thiols that are required for dislocation. An im-
portant advance in our understanding of the component
parts of the machinery that supports vesicle trafficking has
been the identification of a cytosolic, NEM-sensitive fac-
tor, or NSF (8, 16). Since 1 mM of NEM is required to in-
hibit NSF activity in an in vitro assay system, while treat-
ment of intact US21 cells with NEM shows an inhibitory
effect on dislocation/degradation of class I heavy chains at
0.5 mM, we postulate the involvement of factors sensitive
to NEM in dislocation. This property could perhaps be ex-
ploited for the purification of such factors, once an in vitro
system capable of supporting US2/US11-dependent dislo-
cation is available.
Notwithstanding overall inhibition of dislocation by dia-
mide, small amounts of glycosylated class I heavy chains
and a more substantial amount of fully glycosylated TCR
a chains are found in the cytosol of diamide-treated cells
(Figs. 9 and 10). Even though the different reports on the
localization of mammalian N-glycanase are not consonant
(55, 61), this observation suggests that glycosylated pro-
teins can be dislocated and that prior deglycosylation of
proteins is not required for dislocation, in agreement with
our earlier suggestion (63, 64). In addition, N-glycanase
activity has not been detected in Saccharomyces cerevisiae
(46), yet cytosolic degradation of misfolded ER-resident
proteins such as glycosylated CPY* still occurs (19).
Therefore, deglycosylation of ER proteins is not a prereq-
uisite for dislocation.
Diamide also prevents the dislocation of the class I
heavy chains from Daudi cells and the TCR a chain, which
is consistent with the possibility that they are dislocated
via a mechanism similar if not identical to that seen for
US2/US11-catalyzed removal of class I molecules. Early
studies of the degradation of misfolded ER proteins, such
as TCR a chains, immunoglobulin light chains, and HMG-
CoA reductase, show that diamide prevents their break-
down (2, 24, 51). Since these studies did not address the
presence of breakdown intermediates in the cytosol, the
degradation of these molecules was hypothesized to occur
in the ER itself. The mechanism of action of diamide was
believed to involve inactivation of an as yet unidentified
cysteine protease in the ER lumen. Our data suggest that
diamide interferes with degradation by blocking disloca-
tion, rather than by inhibition of a 2SH protease.
The lumenal chaperones BiP (Kar2) and Sec63p are im-
plicated in the degradation of mutant lumenal yeast car-
boxypeptidase Y (42), but their role in the dislocation re-
action is not understood in any mechanistic detail.
However, both diamide and NEM affect cytosolic chaper-
one activity (31, 32). For example, yeast cells transfected
with a plant cDNA of a protein whose amino-terminal end
is homologous to the DnaJ family of chaperones provides
protection to yeast cells treated with diamide (31). Since
other members of the chaperone family aid the transloca-
tion of proteins across a membrane bilayer (14, 49), these
findings suggest that cellular chaperones may be vital to
the dislocation/degradation process of ER proteins and
could constitute a target for NEM and diamide.
The cytosolic destruction of ER proteins is gaining ac-
ceptance as a more generally valid concept. A detailed un-
derstanding of this mechanism will provide insights into
protein translocation across a membrane bilayer and help
identify new factors that contribute to the degradation of
misfolded and abnormal proteins.
The authors would like to thank Drs. Matthew Bogyo and Armin Rehm
for critically evaluating the manuscript.
Domenico Tortorella is supported by a fellowship from The Irvington
Institute for Immunological Research (New York). Craig M. Story is sup-
ported by a Cancer Research Institute Fellowship (New York). Johannes
B. Huppa was supported by the Boehringer Ingelheim Fonds (Stuttgart,
Germany). This work was supported by the National Institutes of Health
and Boehringer-Ingelheim Pharmaceuticals, Inc.
Received for publication 23 December 1997 and in revised form 28 May
1998.
References
1. Abate, C., L. Patel, F.I. Rauscher, and T. Curran. 1990. Redox regulation
of Fos and Jun DNA-binding activity in vitro. Science. 249:1157–1161.
2. Amitay, R., I. Shachar, E. Rabinovich, J. Haimovich, and S. Bar-Nun. 1992.
Degradation of secretory immunoglobulin M in B lymphocytes occurs in
a postendoplasmic reticulum compartment and is mediated by a cysteine
protease. J. Biol. Chem. 267:20694–20700.
3. Bauskin, A., I. Alkalay, and Y. Ben-Neriah. 1991. Redox regulation of a
protein tyrosine kinase in the endoplasmic reticulum. Cell. 66:685–696.
4. Beersma, M., M. Bijlmakers, and H. Ploegh. 1993. Human cytomegalovirus
down-regulates HLA class I expression by reducing the stability of class I
heavy chains. J. Immunol. 151:4455–4464.
5. Biederer, T., C. Volkwein, and T. Sommer. 1996. Degradation of subunits
of the Sec61p complex, an integral component of the ER membrane, by
the ubiquitin-proteasome pathway. EMBO (Eur. Mol. Biol. Organ.) J.
15:2069–2076.
6. Bjorkman, P.J., M.A. Saper, B. Samraoui, W.S. Bennett, J.L. Strominger,
and D.C. Wiley. 1987. Structure of the human class I histocompatibility
antigen HLA-A2. Nature. 329:506–512.
7. Blazquez, M., J.M. Fominaya, and J. Hofsteenge. 1996. Oxidation of sulfhy-
dryl groups of ribonuclease inhibitor in epithelial cells is sufficient for its
intracellular degradation. J. Biol. Chem. 271:18638–18642.
8. Block, M.R., B.S. Glick, C.A. Wilcox, F.T. Wieland, and J.E. Rothman.
1988. Purification of an N-ethylmaleimide-sensitive protein catalyzing ve-
sicular transport. Proc. Natl. Acad. Sci. USA. 85:7852–7856.
9. Bogyo, M., J.S. McMaster, M. Gaczynska, D. Tortorella, A.L. Goldberg,
and H.L. Ploegh. 1997. Covalent modification of the active site threonine
of proteasomal b subunits and the Escherichia coli homolog HslV by a
new class of inhibitors. Proc. Natl. Acad. Sci. USA. 94:6629–6634.
10. Bonifacino, J.S., and R.D. Klausner. 1994. Degradation of proteins re-
tained in the endoplasmic reticulum. In Modern Cell Biology. Cellular
Proteolytic Systems. Vol. 15. A. Ciechanover and A.L. Schwartz, editors.
Wiley-Liss, Inc., New York. 137–160.
11. Braakman, I., J. Helenius, and A. Helenius. 1992. Manipulating disulfide
formation and protein folding in the endoplasmic reticulum. EMBO
(Eur. Mol. Biol. Organ.) J. 11:1717–1722.
12. Brodsky, J.L., and A.A. McCracken. 1997. ER-associated and proteasome-
mediated protein degradation: how two topologically restricted events
came together. Trends Cell Biol. 7:151–156.
13. Chee, M.S., A.T. Bankier, S. Beck, R. Bohni, C.M. Brown, R. Cerny, T.
Horsnell, C.A. Hutchinson, T. Kouzarides, J.A. Martignetti, et al. 1984.
Analysis of the protein-coding content of the sequence of human cytome-
galovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125–169.
14. Clarke, A.R. 1996. Molecular chaperones in protein folding and transloca-
tion. Curr. Opin. Struct. Biol. 6:43–50.
15. Gilbert, H.F. 1997. Protein disulfide isomerase and assisted protein folding.
J. Biol. Chem. 272:29399–29402.The Journal of Cell Biology, Volume 142, 1998 376
16. Glick, B.S., and J.E. Rothman. 1987. Possible role for fatty acyl-coenzyme
A in intracellular protein transport. Nature. 326:309–312.
17. Goodfellow, P.N., E.A. Jones, V. Van Heyningen, M. Solomon, V. Mig-
giano, and W.F. Bodmer. 1975. The b2-microglobulin gene is on chromo-
some 15 and not in the HL-A region. Nature. 254:267–269.
18. Hewitt, C.R., J.R. Lamb, J. Hayball, M. Hill, M.J. Owen, and R.E. O’He-
hir. 1992. Major histocompatibility complex independent clonal T cell an-
ergy by direct interaction of Staphylococcus aureus enterotoxin B with
the T cell antigen receptor. J. Exp. Med. 175:1493–1499.
19. Hiller, M.M., A. Finger, M. Schweiger, and D.H. Wolf. 1996. ER degrada-
tion of a misfolded luminal protein by the cytosolic ubiquitin-proteasome
pathway. Science. 273:1725–1728.
20. Hockenbery, D.M., Z.N. Oltvai, X.-M. Yin, C.L. Milliman, and S.J. Kors-
meyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apop-
tosis. Cell. 75:241–251.
21. Hughes, E.A., C. Hammond, and P. Cresswell. 1997. Misfolded major his-
tocompatibility complex class I heavy chains are translocated into the cy-
toplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA. 94:
1896–1901.
22. Huppa, J.B., and H.L. Ploegh. 1997. The a chain of the T cell receptor is
degraded in the cytosol. Immunity. 7:113–122.
23. Hwang, C., A.J. Sinskey, and H.F. Lodish. 1992. Oxidized redox state of
glutathione in the endoplasmic reticulum. Science. 257:1497–1502.
24. Inoue, S., and R.D. Simoni. 1992. 3-Hydroxy-3-methylglutaryl-coenzyme A
reductase and T cell receptor a subunit are differentially degraded in the
endoplasmic reticulum. J. Biol. Chem. 267:9080–9086.
25. Jensen, T.J., M.A. Loo, S. Pind, D.B. Williams, A.L. Goldberg, and J.R. Ri-
ordan. 1995. Multiple proteolytic systems, including the proteasome, con-
tribute to CFTR processing. Cell. 83:129–135.
26. Jones, T.R., L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, and A.E.
Campbell. 1995. Multiple independent loci within the human cytomega-
lovirus unique short region down regulates expression of major histo-
compatibility complex class I heavy chains. J. Virol. 69:4830–4841.
27. Kim, H.-J., C. Gatz, W. Hillen, and T.R. Jones. 1994. Tetracycline repres-
sor-regulated gene expression in recombinant human cytomegalovirus. J.
Virol. 69:2565–2573.
28. Kopito, R.R. 1997. ER quality control: the cytoplasmic connection. Cell.
88:427–430.
29. Kosower, E.M., and N.S. Kosower. 1969. Lest I forget thee, glutathione.
Nature. 224:117–120.
30. Kosower, N.S., and E.M. Kosower. 1995. Diamide: an oxidant probe for
thiols. Methods Enzymol. 251:123–133.
31. Kushnir, S., E. Babiychuk, K. Kampfenkel, E. Belles-Boix, M. Van Mon-
tagu, and D. Inze. 1995. Characterization of Arabidopsis thaliana cDNAs
that render yeasts tolerant toward the thiol-oxidizing drug diamide. Proc.
Natl. Acad. Sci. USA. 92:10580–10584.
32. Liu, Q., E.J. Levy, and W.J. Chirico. 1996. N-ethylmaleimide inactivates a
nucleotide-free Hsp70 molecular chaperone. J. Biol. Chem. 271:29937–
29944.
33. Marchetti, P., D. Decaudin, A. Macho, N. Zamzami, T. Hirsch, S.A. Susin,
and G. Kroemer. 1997. Redox regulation of apoptosis: impact of thiol ox-
idation status on mitochondrial function. Eur. J. Immunol. 27:289–296.
34. Maudsley, D.J., and J.D. Pound. 1991. Modulation of MHC antigen expres-
sion by viruses and oncogenes. Immunol. Today. 12:429–431.
35. McCracken, A.A., and J.L. Brodsky. 1996. Assembly of ER-associated pro-
tein degradation in vitro: dependence on cytosol, calnexin, and ATP. J.
Cell Biol. 132:291–298.
36. Neefjes, J.J., and H.L. Ploegh. 1988. Allele and locus-specific differences in
the association of MHC Class I H-chain with b2-microglobulin and cell
surface expression. Eur. J. Immunol. 18:801–810.
37. Nilsson, K., P.-E. Evrin, and K.I. Welsh. 1974. Production of b2-microglob-
ulin by normal and malignant human cell lines and peripheral lympho-
cytes. Transplant. Rev. 21:53–84.
38. Noiva, R., and W.J. Lennarz. 1992. Protein disulfide isomerase. J. Biol.
Chem. 267:3553–3556.
39. Parham, P., C.J. Barnstable, and W.F. Bodmer. 1979. Use of monoclonal
antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immu-
nol. 123:342–349.
40. Peyrieras, N., E. Bause, G. Legler, R. Vasilov, L. Claesson, P. Peterson,
and H.L. Ploegh. 1983. Effects of the glucosidase inhibitors nojirimycin
and deoxynojirimycin on the biosynthesis of membrane and secretory
glycoproteins. EMBO (Eur. Mol. Biol. Organ.) J. 2:823–832.
41. Pilon, M., R. Schekman, and K. Römish. 1997. Sec61p mediates export of a
misfolded secretory protein from the endoplasmic reticulum to the cyto-
sol for degradation. EMBO (Eur. Mol. Biol. Organ.) J. 16:4540–4548.
42. Plemper, R.K., S. Bohmler, J. Bordallo, T. Sommer, and D.H. Wolf. 1997.
Mutant analysis links the translocon and BiP to retrograde protein trans-
port for ER degradation. Nature. 388:891–895.
43. Ploegh, H.L. 1995. One-dimensional isoelectric focusing of proteins in slab
gels. In Current Protocol in Protein Science. Vol. 1. J.E. Coligan, B.M.
Dunn, H.L. Ploegh, D.W. Speicher, and P.T. Wingfield, editors. John
Wiley and Sons, New York. 10.2.1–10.2.8.
44. Rapoport, T.A., B. Jungnickel, and U. Kutay. 1996. Protein transport
across the eukaryotic endoplasmic reticulum and bacterial inner mem-
branes. Annu. Rev. Biochem. 65:271–303.
45. Robb, R.J., C. Terhorst, and J.L. Strominger. 1978. Sequence of the COOH-
terminal hydrophilic region of histocompatibility antigens HLA-A2 and
HLA-B7. J. Biol. Chem. 253:5319–5324.
46. Romisch, K., and B.R.S. Ali. 1997. Similar processes mediate glycopeptide
export from the endoplasmic reticulum in mammalian cells and Saccha-
romyces cerevisiae. Proc. Natl. Acad. Sci. USA. 94:6730–6734.
47. Saper, M.A., P.J. Bjorkman, and D.C. Wiley. 1991. Refined structure of the
human histocompatibility antigen HLA-A2 at 2.6Å resolution. J. Mol.
Biol. 219:277–319.
48. Sato, N., S. Iwata, K. Nakamura, T. Hori, K. Mori, and J. Yodoi. 1995.
Thiol-mediated redox regulation of apoptosis. J. Immunol. 154:3194–
3203.
49. Schatz, G., and B. Dobberstein. 1996. Common principles of protein trans-
location across membranes. Science. 271:1519–1526.
50. Shamu, C.E. 1997. Signal transduction: splicing together the unfolded-pro-
tein response. Curr. Biol. 7:R67–R70.
51. Stafford, F.J., and J.S. Bonifacino. 1991. A permeabilized cell system iden-
tifies the endoplasmic reticulum as a site of protein degradation. J. Cell
Biol. 115:1225–1236.
52. Stam, N.J., H. Spits, and H.L. Ploegh. 1986. Monoclonal antibodies raised
against denatured HLA-B locus heavy chains permit biochemical charac-
terization of certain HLA-C locus products. J. Immunol. 137:2299–2306.
53. Stam, N.J., T.M. Vroom, P.J. Peters, E.B. Pastoors, and H.L. Ploegh. 1990.
HLA-A- and HLA-B- specific monoclonal antibodies reactive with free
heavy chains in Western blots, in formalin-fixed, paraffin-embedded
tissue sections and in cryo-immuno-electron microscopy. Int. Immunol.
2:113–125.
54. Suthanthiran, M., M.E. Anderson, V.K. Sharma, and A. Meister. 1990.
Glutathione regulates activation-dependent DNA synthesis in highly pu-
rified normal human T lymphocytes via the CD2 and CD3 antigens. Proc.
Natl. Acad. Sci. USA. 87:3343–3347.
55. Suzuki, T., A. Seko, K. Kitajima, Y. Inoue, and S. Inoue. 1994. Purification
and enzymatic properties of peptide: N-glycanase from C3H mouse-
derived L-929 fibroblast cells. J. Biol. Chem. 269:17611–17618.
56. Toledano, M.B., and W.J. Leonard. 1991. Modulation of transcription fac-
tor NF-kB binding activity by oxidation-reduction in vitro. Proc. Natl.
Acad. Sci. USA. 88:4328–4332.
57. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I re-
stricted T-lymphocytes. Ann. Rev. Immunol. 7:601–624.
58. Valetti, C., and R. Sitia. 1994. The differential effects of dithiothreitol and
2-mercaptoethanol on the secretion of partially and completely assem-
bled immunoglobulins suggest that thiol-mediated retention does not
take place in or beyond the Golgi. Mol. Biol. Cell. 5:1311–1324.
59. Van de Rijn, M., A.H.H. Geurts van Kessel, V. Kroezen, A.J. Van Ag-
thoven, K. Verstijnen, C. Terhorst, and J. Hilgers. 1983. Localization of a
gene controlling the expression of the human transferrin receptor to the
region q12-qter of chromosome 3. Cytogenet. Cell Genet. 36:525.
60. Ward, C.L., S. Omura, and R.R. Kopito. 1995. Degradation of CFTR by
the ubiquitin–proteasome pathway. Cell. 83:121–127.
61. Weng, S., and R.G. Spiro. 1997. Demonstration of a peptide: N-glycosidase
in the endoplasmic reticulum of rat liver. Biochem. J. 322:655–661.
62. Werner, E.D., J.L. Brodsky, and A.A. McCracken. 1996. Proteasome-
dependent endoplasmic reticulum-associated protein degradation: an un-
conventional route to a familiar fate. Proc. Natl. Acad. Sci. USA. 93:
13797–13801.
63. Wiertz, E.J.H.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L.
Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates
MHC Class I heavy chains from the endoplasmic reticulum to the cyto-
sol. Cell. 84:769–779.
64. Wiertz, E.J.H.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones,
T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a
membrane protein from the endoplasmic reticulum to the proteasome
for destruction. Nature. 384:432–438.
65. Wiertz, E.J.H.J., S. Mukherjee, and H.L. Ploegh. 1997. Viruses use stealth
technology to escape from the host immune system. Mol. Med. Today.
3:116–123.
66. Yu, H., G. Kaung, S. Kobayashi, and R.R. Kopito. 1997. Cytosolic degrada-
tion of T-cell receptor a chains by the proteasome. J. Biol. Chem. 272:
20800–20804.
67. Zinkernagel, R.M. 1996. Immunology taught by viruses. Science. 271:173–178.